Jan 06, 2026
FDA Flags Liver Injury Risk In Sanofi’s Rejected Multiple Sclerosis Drug

In December 2025, the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) for Sanofi SA's (NASDAQ:SNY) new drug application of tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis (nrSPMS) in adult patients. The press release was…

Jan 06, 2026
Accenture To Acquire UK AI Firm Faculty To Scale Enterprise AI

Accenture Plc (NYSE:ACN) announced on Tuesday that it has agreed to acquire Faculty, a UK-based artificial intelligence firm, further strengthening its push to integrate advanced AI into enterprise operations. The move reflects growing demand from businesses and governments for AI…

Jan 06, 2026
Lucid Gravity Can Now Navigate City Canyons With Trimble Tech

Lucid Group, Inc. (NASDAQ:LCID) stock rose Tuesday after Trimble Inc. (NASDAQ:TRMB) announced that its advanced positioning technology will power navigation and driver assistance systems in the automaker’s upcoming Gravity electric SUV. Trimble said its RTX and ProPoint Go technologies will…